The Enterprise Value as of December 2024 (TTM) for Equillium, Inc. (EQ) is 7.93M

According to Equillium, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.93M. This represents a change of -66.45% compared to the average of 23.64M of the last 4 quarters.

Equillium, Inc. (EQ) Historical Enterprise Value (quarterly & annually)

How has EQ Enterprise Value performed in the past?

The mean historical Enterprise Value of Equillium, Inc. over the last ten years is 74.66M. The current 7.93M Enterprise Value has changed 962.14% with respect to the historical average. Over the past ten years (40 quarters), EQ's Enterprise Value was at its highest in in the September 2018 quarter at 240.37M. The Enterprise Value was at its lowest in in the December 2022 quarter at -12493058.44.

Equillium, Inc. (EQ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Equillium, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Equillium, Inc. (EQ) Average Enterprise Value

How has EQ Enterprise Value performed in the past?

The current Enterprise Value of Equillium, Inc. (EQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Equillium, Inc. (EQ) Enterprise Value vs. Peers

How is EQ’s Enterprise Value compared to its peers?

Equillium, Inc.’s Enterprise Value is less than Lyra Therapeutics, Inc. (22.80M), greater than HOOKIPA Pharma Inc. (-38628737.00), greater than LianBio (-66141903.00), less than Jasper Therapeutics, Inc. (235.25M), greater than Cingulate Inc. (5.81M), less than SAB Biotherapeutics, Inc. (33.19M), less than Anebulo Pharmaceuticals, Inc. (40.61M), less than Cadrenal Therapeutics, Inc. Common Stock (20.14M), less than Monopar Therapeutics Inc. (110.36M), greater than Spero Therapeutics, Inc. (-20557187.00), less than Bolt Biotherapeutics, Inc. (28.44M), less than Coherus BioSciences, Inc. (303.30M), less than Gracell Biotechnologies Inc. (5.66B), greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than Ikena Oncology, Inc. (37.04M), greater than Werewolf Therapeutics, Inc. (-17421672.00), less than Edgewise Therapeutics, Inc. (2.76B), greater than Quoin Pharmaceuticals, Ltd. (-667131.00), greater than Pasithea Therapeutics Corp. (-6092141.00), less than aTyr Pharma, Inc. (138.44M), less than Trevi Therapeutics, Inc. (342.52M), less than Cue Biopharma, Inc. (41.08M), greater than AN2 Therapeutics, Inc. (7.13M), greater than BioAtla, Inc. (-25261721.00),

Build a custom stock screener for Equillium, Inc. (EQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Equillium, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Equillium, Inc. (EQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Equillium, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.